Tredje AP fonden Grows Position in Align Technology, Inc. $ALGN

Tredje AP fonden boosted its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 19.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 156,991 shares of the medical equipment provider’s stock after purchasing an additional 25,759 shares during the period. Tredje AP fonden’s holdings in Align Technology were worth $19,658,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Atria Investments Inc grew its stake in shares of Align Technology by 4.9% during the second quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock valued at $298,000 after buying an additional 74 shares during the last quarter. Arizona State Retirement System boosted its holdings in Align Technology by 0.4% during the 3rd quarter. Arizona State Retirement System now owns 20,387 shares of the medical equipment provider’s stock valued at $2,553,000 after acquiring an additional 79 shares during the period. Sentry Investment Management LLC boosted its holdings in Align Technology by 73.1% during the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 79 shares during the period. Rothschild Investment LLC grew its position in Align Technology by 140.3% in the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 87 shares during the last quarter. Finally, Royal London Asset Management Ltd. increased its stake in Align Technology by 0.3% in the second quarter. Royal London Asset Management Ltd. now owns 31,629 shares of the medical equipment provider’s stock worth $5,988,000 after purchasing an additional 93 shares during the period. Institutional investors own 88.43% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ALGN shares. Stifel Nicolaus boosted their target price on shares of Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Weiss Ratings upgraded shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, January 16th. Robert W. Baird set a $218.00 price objective on shares of Align Technology in a research report on Thursday, February 5th. UBS Group raised their target price on shares of Align Technology from $175.00 to $185.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Leerink Partners boosted their price target on Align Technology from $210.00 to $225.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $195.58.

Align Technology Stock Performance

Shares of ALGN opened at $190.02 on Friday. The company has a 50 day moving average price of $169.74 and a 200-day moving average price of $149.29. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $208.30. The stock has a market capitalization of $13.63 billion, a PE ratio of 33.57, a PEG ratio of 2.08 and a beta of 1.84.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. Align Technology’s revenue was up 5.3% compared to the same quarter last year. During the same period last year, the company posted $2.44 earnings per share. Equities research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Insider Activity at Align Technology

In other news, EVP John Morici sold 7,969 shares of the business’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total value of $1,508,611.39. Following the completion of the transaction, the executive vice president directly owned 8,237 shares of the company’s stock, valued at approximately $1,559,346.47. The trade was a 49.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.66% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.